This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
De Silva S, Fisher C, Premawardhena A, Lamabadusuriya S, Peto T, Perera G, et al. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. The Lancet, 2000. 355(9206): p. 786-791.10.1016/S0140-6736(99)08246-XDe SilvaSFisherCPremawardhenaALamabadusuriyaSPetoTPereraGThalassaemia in Sri Lanka: implications for the future health burden of Asian populationsThe Lancet20003559206786791Open DOISearch in Google Scholar
Weatherall DJ. Thalassaemias. In: eLS. Chichester: John Wiley and Sons; 2001. doi: 10.1002/9780470015 902.a0002274.pub2WeatherallDJThalassaemiasIn: eLSChichesterJohn Wiley and Sons2001doi: 10.1002/9780470015 902.a0002274.pub210.1002/9780470015902.a0005536.pub2Search in Google Scholar
Weatherall DJ, Clegg JB. The thalassaemia syndromes, 4th edition, Oxford: Blackwell Science; 2001. doi: 10.1002/9780470696705WeatherallDJCleggJBThe thalassaemia syndromes, 4th editionOxfordBlackwell Science2001doi: 10.1002/978047069670510.1002/9780470696705Search in Google Scholar
Fucharoen S, Winichagoon P. Prevention and control of thalassemia in Asia. Asian Biomed, 2010; 1:1-6.FucharoenSWinichagoonPPrevention and control of thalassemia in AsiaAsian Biomed2010116Search in Google Scholar
U.S. Department of Health and Human Services. International Thalassemia Awareness. Centers for Disease Control and Prevention [on line] 2016 [cited 2016 May 26], Available from: https://www.cdc.gov/features/international-thalassemia/index.htmlU.S. Department of Health and Human Services. International Thalassemia Awareness. Centers for Disease Control and Prevention [on line] 2016 [cited 2016 May 26]Available from: https://www.cdc.gov/features/international-thalassemia/index.htmlSearch in Google Scholar
Thavorncharoensap M, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol BO. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Hematol. 2010; 10:1. doi: 10.1186/1471-2326-10-1.10.1186/1471-2326-10-1ThavorncharoensapMTorcharusKNuchprayoonIRiewpaiboonAIndaratnaKUbolBOFactors affecting health-related quality of life in Thai children with thalassemiaBMC Hematol2010101doi: 10.1186/1471-2326-10-1283699220180983Open DOISearch in Google Scholar
Fucharoen S, Winichagoon P. Haemoglobinopathies in Southeast Asia. Indian J Med Res. 2011; 134: 498-506.22089614FucharoenSWinichagoonPHaemoglobinopathies in Southeast AsiaIndian J Med Res2011134498506Search in Google Scholar
Eleftheriou A, Angastiniotis M. A Report on Thalassaemia The Association of South East Asian Nations [ASEAN], 2013, Thalassaemia International Federation (TIF). p. 14.EleftheriouAAngastiniotisMA Report on Thalassaemia The Association of South East Asian Nations [ASEAN]2013Thalassaemia International Federation (TIF)14Search in Google Scholar
Balveer K, Pyar K, Wonke B, Combined oral and parenteral iron chelation in beta thalassaemia major. Med J Malaysia. 2000; 55: 493-7.11221163BalveerKPyarKWonkeBCombined oral and parenteral iron chelation in beta thalassaemia majorMed J Malaysia2000554937Search in Google Scholar
Fucharoen S, Winichagoon P. New updating into hemoglobinopathies. Int J Lab Hematol. 2012; 34: 559-65.2276234810.1111/j.1751-553X.2012.01446.xFucharoenSWinichagoonPNew updating into hemoglobinopathiesInt J Lab Hematol2012345596522762348Search in Google Scholar
Galanello R, Origa R. Review: beta-thalassemia. Orphanet J Rare Dis. 2010; 5:1-15.GalanelloROrigaRReview: beta-thalassemiaOrphanet J Rare Dis2010511510.1186/1750-1172-5-11289311720492708Search in Google Scholar
Pedram M, Zandian K, Keikhaie B, Akramipour R, Hashemi A. Ghahfarokhi FK, et al. A report on chelating therapy and patient compliance by determination of serum ferritin levels in 243 thalassemia major patients. Iranian Journal of Pediatric Society. 2010; 2:65-9.PedramMZandianKKeikhaieBAkramipourRHashemiAGhahfarokhiFKA report on chelating therapy and patient compliance by determination of serum ferritin levels in 243 thalassemia major patientsIranian Journal of Pediatric Society20102659Search in Google Scholar
Schrier SL, Angelucci E. New strategies in the treatment of the thalassemias. Annu Rev Med. 2005; 56:157-71.10.1146/annurev.med.56.082103.10471815660507SchrierSLAngelucciENew strategies in the treatment of the thalassemiasAnnu Rev Med2005561577115660507Open DOISearch in Google Scholar
Nadarajan V. Modern management of thalassemia. ISBT Science Series. 2011; 6:432-7.10.1111/j.1751-2824.2011.01528.xNadarajanVModern management of thalassemiaISBT Science Series201164327Open DOISearch in Google Scholar
Ministry of Health, Malaysia. Management of Thalassaemia. Health Technology Assessment Unit. [on line] 2003 [cited 2016 Apr 14], p. 137, Available from: http://www.moh.gov.my/english.php/pages/view/199Ministry of Health, Malaysia. Management of Thalassaemia. Health Technology Assessment Unit.[on line] 2003 [cited 2016 Apr 14]137Available from: http://www.moh.gov.my/english.php/pages/view/199Search in Google Scholar
Sheth S. Iron chelation: an update. Curr Opin Hematol. 2014; 21:179-85.10.1097/MOH.000000000000003124504090ShethSIron chelation: an updateCurr Opin Hematol2014211798524504090Open DOISearch in Google Scholar
Shander A, Sazama K, Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy. Transfusion. 2010; 50:1144-55.10.1111/j.1537-2995.2009.02551.x20088842ShanderASazamaKClinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapyTransfusion20105011445520088842Open DOISearch in Google Scholar
Kidson-Gerber GL, Francis S, Lindeman R. Management and clinical outcomes of transfusion-dependent thalassaemia major in an Australian tertiary referral clinic. Med J Aust. 2008; 188:72-5.Kidson-GerberGLFrancisSLindemanRManagement and clinical outcomes of transfusion-dependent thalassaemia major in an Australian tertiary referral clinicMed J Aust200818872510.5694/j.1326-5377.2008.tb01525.xSearch in Google Scholar
Prabhu R, Prabhu V, Prabhu R. Iron overload in beta thalassemia - a review. J Biosci Tech. 2009; 1:20-31.PrabhuRPrabhuVPrabhuRIron overload in beta thalassemia - a reviewJ Biosci Tech200912031Search in Google Scholar
Wong C, Richardson DR. β-Thalassaemia: emergence of new and improved iron chelators for treatment. Int J Biochem Cell Biol. 2003; 35:1144-9.1267248410.1016/S1357-2725(03)00046-3WongCRichardsonDRβ-Thalassaemia: emergence of new and improved iron chelators for treatmentInt J Biochem Cell Biol20033511449Search in Google Scholar
Crisponi G, Remelli M. Iron chelating agents for the treatment of iron overload. Coord Chem Rev. 2008; 252:1225-40.10.1016/j.ccr.2007.12.014CrisponiGRemelliMIron chelating agents for the treatment of iron overloadCoord Chem Rev2008252122540Open DOISearch in Google Scholar
Porter JB. Optimizing iron chelation strategies in P-thalassaemia major. Blood Rev. 2009; 23:S3-S7.10.1016/S0268-960X(09)70003-7PorterJBOptimizing iron chelation strategies in P-thalassaemia majorBlood Rev200923S3S7Open DOISearch in Google Scholar
Berdoukas V, Farmaki K, Wood JC, Coates T. Iron chelation in thalassemia: time to reconsider our comfort zones. Expert Rev Hematol. 2011; 4:17-26.10.1586/ehm.10.7421322775BerdoukasVFarmakiKWoodJCCoatesTIron chelation in thalassemia: time to reconsider our comfort zonesExpert Rev Hematol201141726Open DOISearch in Google Scholar
Ministry of Health, Malaysia, Management of transfusion dependent thalassaemia. Medical Development division: Putrajaya. [on line] 2009 [cited 2016 Apr 14]; pp. 1-99, Available from: http://www.mpaweb.org.my/file_dir/20755646044c43fcce36af5.pdfMinistry of Health, Malaysia, Management of transfusion dependent thalassaemia. Medical Development division: Putrajaya.[on line] 2009 [cited 2016 Apr 14]199Available from: http://www.mpaweb.org.my/file_dir/20755646044c43fcce36af5.pdfSearch in Google Scholar
Thalassaemia International Federation, Thalassaemia Foundation of Thailand, and Mahidol University. 1st Pan-Asian conference on haemoglobinopathies. February 8-10, 2012. Bangkok, Thailand. Thalassemia Reports, 2012; 2 (s1):1-46. doi: 10.4081/thal.2012.s1.Thalassaemia International Federation, Thalassaemia Foundation of Thailand, and Mahidol University1st Pan-Asian conference on haemoglobinopathies. February 8-10, 2012Bangkok, ThailandThalassemia Reports20122(s1)146doi: 10.4081/thal.2012.s110.4081/thal.2012.s1Search in Google Scholar
Cianciulli P. Iron chelation therapy in thalassemia syndromes. Mediterranean Journal of Hematology and Infectious Diseases. 2009; 1:e2009034. doi: 10.4084/MJHID.2009.034.2141599910.4084/mjhid.2009.0034CianciulliPIron chelation therapy in thalassemia syndromesMediterranean Journal of Hematology and Infectious Diseases20091e2009034doi: 10.4084/MJHID.2009.034Search in Google Scholar
Cappellini MD. Long-term efficacy and safety of deferasirox. Blood Rev. 2008; 22 (Suppl 2):S35-41.10.1016/S0268-960X(08)70007-919059055CappelliniMDLong-term efficacy and safety of deferasiroxBlood Rev200822(Suppl 2)S3541Open DOISearch in Google Scholar
Poggiali E, Cassinerio E, Zanaboni L, Cappellini MD. An update on iron chelation therapy. Blood Transfus. 2012; 10:411-22.22790257PoggialiECassinerioEZanaboniLCappelliniMDAn update on iron chelation therapyBlood Transfus20121041122Search in Google Scholar
Musallam KM, Angastiniotis M, Eleftheriou A, Porter JB. Cross-talk between available guidelines for the management of patients with betα-thalassemia major. Acta Haematol. 2013; 130:64-73.10.1159/00034573423485589MusallamKMAngastiniotisMEleftheriouAPorterJBCross-talk between available guidelines for the management of patients with betα-thalassemia majorActa Haematol2013130647323485589Open DOISearch in Google Scholar
Verissimo MPdA, Loggetto SR, Fabron Junior A, Baldanzi GR, Hamerschlak N, Fernandes JL, et al. Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion. Rev Bras Hematol Hemoter. 2013; 35: 428-34.24478610VerissimoMPdALoggettoSRFabron JuniorABaldanziGRHamerschlakNFernandesJLBrazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusionRev Bras Hematol Hemoter2013354283410.5581/1516-8484.20130106390582624478610Search in Google Scholar
Cohen AR. New advances in iron chelation therapy. Hematology (ASH Education Book). 2006; 1:42-47.CohenARNew advances in iron chelation therapyHematology (ASH Education Book)20061424710.1182/asheducation-2006.1.4217124038Search in Google Scholar
Aimiuwu E, Thomas A. Roheemun N, Khairallah T, Georgiou A, Papadopoulou C. A guide for the haemoglobinopathy nurse. Nicosia (Cyprus): Thalassaemia International Federation; 2012.AimiuwuEThomasARoheemunNKhairallahTGeorgiouAPapadopoulouCA guide for the haemoglobinopathy nurseNicosia (Cyprus)Thalassaemia International Federation2012Search in Google Scholar
Vichinsky E. Iron overload and iron chelation therapy in pediatric patients. US Hematology. 2009; 2:64-7. doi: 10.17925/OHR.2009.02.0.64.VichinskyEIron overload and iron chelation therapy in pediatric patientsUS Hematology20092647doi: 10.17925/OHR.2009.02.0.6410.17925/OHR.2009.02.0.64Search in Google Scholar
Neufeld EJ. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood. 2006; 107:3436-41.1662776310.1182/blood-2006-02-002394NeufeldEJOral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questionsBlood2006107343641189576516627763Search in Google Scholar
Jamuar SS. Lai AH. Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia. Ther Adv Hematol. 2012; 3: 299-307.2361691710.1177/2040620712450252JamuarSSLaiAHSafety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemiaTher Adv Hematol20123299307362731823616917Search in Google Scholar
Naithani R, Chandra J, Sharma S. Safety of oral iron chelator deferiprone in young thalassaemics. Eur J Haematol. 2005; 74:217-20.1569379110.1111/j.1600-0609.2004.00377.xNaithaniRChandraJSharmaSSafety of oral iron chelator deferiprone in young thalassaemicsEur J Haematol2005742172015693791Search in Google Scholar
Galanello R. Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective. Ther Clin Risk Manag. 2007; 3:795-805.18473004GalanelloRDeferiprone in the treatment of transfusion-dependent thalassemia: a review and perspectiveTher Clin Risk Manag20073795805Search in Google Scholar
Jamuar SS, Lai AHM, Tan AM, Chan MY, Tan ES, Ng ISL. Use of deferiprone for iron chelation in patients with transfusion dependent thalassaemia. J Paediatr Child Health. 2011; 47:812-7.10.1111/j.1440-1754.2011.02031.x21902752JamuarSSLaiAHMTanAMChanMYTanESNgISLUse of deferiprone for iron chelation in patients with transfusion dependent thalassaemiaJ Paediatr Child Health201147812721902752Open DOISearch in Google Scholar
Cappellini DM, Cohen A, Porter J, Taher A, Viprakasit V, editors. Guidelines for the management of transfusion dependent thalassemia (TDT). 3rd ed. Nicosia (Cyprus): Thalassaemia International Federation; 2014.CappelliniDMCohenAPorterJTaherAViprakasitVeditorsGuidelines for the management of transfusion dependent thalassemia (TDT)3rd edNicosia (Cyprus)Thalassaemia International Federation2014Search in Google Scholar
Algren DA. Review of oral iron chelators (deferiprone and deferasirox) for the treatment of iron overload in pediatric patients. World Health Organization [on line] 2010 [cited 2016 Dec 01] pp. 1-22. Available from: http://www.who.int/selection_medicines/committees/expert/18/applications/OralIronChelators.pdfAlgrenDAReview of oral iron chelators (deferiprone and deferasirox) for the treatment of iron overload in pediatric patients. World Health Organization [on line] 2010 [cited 2016 Dec 01]122Available from: http://www.who.int/selection_medicines/committees/expert/18/applications/OralIronChelators.pdfSearch in Google Scholar
Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood. 2011; 118:3479-88.10.1182/blood-2010-08-300335RachmilewitzEAGiardinaPJHow I treat thalassemiaBlood201111834798821813448Open DOISearch in Google Scholar
Aydinok Y, Kattamis A, Viprakasit V Current approach to iron chelation in children. Br J Haematol. 2014; 165: 745-55.2464601110.1111/bjh.12825AydinokYKattamisAViprakasit V Current approach to iron chelation in childrenBr J Haematol20141657455524646011Search in Google Scholar
Kwiatkowski JL. Real-world use of iron chelators. Hematology Am Soc Hematol Educ Program. 2011; 2011:451-58.22160073KwiatkowskiJLReal-world use of iron chelatorsHematology Am Soc Hematol Educ Program201120114515810.1182/asheducation-2011.1.45122160073Search in Google Scholar
Choudhry V, Naithani R. Current status of iron overload and chelation with deferasirox. Indian J Pediatr. 2007; 74:759-64.10.1007/s12098-007-0134-717785900ChoudhryVNaithaniRCurrent status of iron overload and chelation with deferasiroxIndian J Pediatr2007747596417785900Open DOISearch in Google Scholar
Maggio A, Filosa A, Vitrano A, Aloj G, Kattamis A, Ceci A, et al. Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trials. Blood Cells Mol Dis. 2011; 47:166-75.10.1016/j.bcmd.2011.07.00221843958MaggioAFilosaAVitranoAAlojGKattamisACeciAIron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trialsBlood Cells Mol Dis2011471667521843958Open DOISearch in Google Scholar
Galanello R, Agus A, Campus S, Danjou F, Giardina PJ, Grady RW. Combined iron chelation therapy. Ann N Y Acad Sci. 2010; 1202:79-86.2071277710.1111/j.1749-6632.2010.05591.xGalanelloRAgusACampusSDanjouFGiardinaPJGradyRWCombined iron chelation therapyAnn N Y Acad Sci20101202798620712777Search in Google Scholar
Sayani F, Warner M, Wu J, Wong-Rieger D, Humphreys K, Odame I. Guidelines for the clinical care of patients with thalassemia in Canada. Toronto: Anemia Institute for Research and Education. [on line] 2012 [cited 2016 Apr 14] Available from: http://www.thalassemia.ca/wp-content/uploads/Thalassemia-Guidelines_ LR.pdfSayaniFWarnerMWuJWong-RiegerDHumphreysKOdameIGuidelines for the clinical care of patients with thalassemia in Canada. Toronto: Anemia Institute for Research and Education. [on line] 2012 [cited 2016 Apr 14]Available from: http://www.thalassemia.ca/wp-content/uploads/Thalassemia-Guidelines_ LR.pdfSearch in Google Scholar
Kremastinos DT, Farmakis D. Iron overload cardiomyopathy in clinical practice. Circulation. 2011; 124:2253-63.10.1161/CIRCULATIONAHA.111.05077322083147KremastinosDTFarmakisDIron overload cardiomyopathy in clinical practiceCirculation201112422536322083147Open DOISearch in Google Scholar
Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, et al., Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion. 2014; 54:972-81.10.1111/trf.1234823889533VichinskyENeumayrLTrimbleSGiardinaPJCohenARCoatesTTransfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)Transfusion20145497281441083523889533Open DOISearch in Google Scholar
Viprakasit V, Gattermann N, Lee JW, Porter JB, Taher AT, Habr D, et al. Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemias. Blood Transfus. 2013; 11:108-22.22871821ViprakasitVGattermannNLeeJWPorterJBTaherATHabrDGeographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemiasBlood Transfus20131110822Search in Google Scholar
Ngim CF, Ibrahim H, Lai NM, Ng C. A single centre study on birth of children with transfusion dependent thalassaemia in Malaysia and reasons for ineffective prevention. Prenat Diagn. 2015; 35:51-9.10.1002/pd.448425156332NgimCFIbrahimHLaiNMNgCA single centre study on birth of children with transfusion dependent thalassaemia in Malaysia and reasons for ineffective preventionPrenat Diagn20153551925156332Open DOISearch in Google Scholar
Ngim CF, Lai NM, Ibrahim H, Ratnasingam V Attitudes towards prenatal diagnosis and abortion in a multiethnic country: a survey among parents of children with thalassaemia major in Malaysia. J Community Genet. 2013; 4:215-21.10.1007/s12687-012-0133-xNgimCFLaiNMIbrahimHRatnasingamVAttitudes towards prenatal diagnosis and abortion in a multiethnic country: a survey among parents of children with thalassaemia major in MalaysiaJ Community Genet2013421521366684223296641Open DOISearch in Google Scholar
Dahlui M, Hishamshah M, Rahman A, Aljunid S. Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment. Singapore Med J. 2009; 50:794-9.19710979DahluiMHishamshahMRahmanAAljunidSQuality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatmentSingapore Med J2009507949Search in Google Scholar
Riewpaiboon A, Nuchprayoon I, Torcharus K, Indaratna K, Thavorncharoensap M, Ubol B-o. Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children. BMC Res Notes. 2010; 3:29. doi: 10.1186/1756-0500-3-29.RiewpaiboonANuchprayoonITorcharusKIndaratnaKThavorncharoensapMUbolB-oEconomic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai childrenBMC Res Notes2010329doi: 10.1186/1756-0500-3-2910.1186/1756-0500-3-29283571920181056Search in Google Scholar
Singapore Department of Statistics. Population Trends 2014. Republic of Singapore. [on line] 2014 [cited 2016 Apr 14]. Available from: http://www.nas.gov.sg/archivesonline/data/pdfdoc/20141002003/notice_of_publication_-_population_trends_2014. pdfSingapore Department of Statistics. Population Trends 2014. Republic of Singapore. [on line] 2014 [cited 2016 Apr 14].Available from: http://www.nas.gov.sg/archivesonline/data/pdfdoc/20141002003/notice_of_publication_-_population_trends_2014. pdfSearch in Google Scholar
Tan ES, Koh C, Law HY, Tan GP, Lai AHM, Ng ISL. Haemoglobin E-beta thalassemia in Singapore. Ann Acad Med Singapore. 2014; 43:331-3.25028144TanESKohCLawHYTanGPLaiAHMNgISLHaemoglobin E-beta thalassemia in SingaporeAnn Acad Med Singapore201443331310.47102/annals-acadmedsg.V43N6p331Search in Google Scholar
Viprakasit V, Lee-Lee C, Chong QT, Lin K-H, Khuhapinant A. Iron chelation therapy in the management of thalassemia: the Asian perspectives. Int J Hematol. 2009; 90: 435-45.1986260210.1007/s12185-009-0432-0ViprakasitVLee-LeeCChongQTLinK-HKhuhapinantAIron chelation therapy in the management of thalassemia: the Asian perspectivesInt J Hematol2009904354519862602Search in Google Scholar
Thalassaemia International Federation. 2nd Pan-Asian Conference on Haemoglobinopathies 27-28 December 2015: JW Marriott Hanoi Hotel, Vietnam.Thalassaemia International Federation. 2nd Pan-Asian Conference on Haemoglobinopathies 27-28 December 2015JW Marriott Hanoi Hotel, Vietnam1108Search in Google Scholar
Health Technology Assessment Indonesia. Pencegahan Thalassemia 2009. [on line] 2010 [cited 2016 Apr 14]; p. 92, Available from: https://www.scribd.com/doc/52216165/Pencegahan-ThalassemiaHealth Technology Assessment Indonesia. Pencegahan Thalassemia 2009[on line] 2010 [cited 2016 Apr 14]92Available from: https://www.scribd.com/doc/52216165/Pencegahan-ThalassemiaSearch in Google Scholar
Ethnic Groups Philippines. Ethnic Groups of the Philippines. [on line] 2011 [cited 2016 Apr 14]; Available from: http://www.ethnicgroupsphilippines.com/Ethnic Groups Philippines. Ethnic Groups of the Philippines[on line] 2011 [cited 2016 Apr 14]; Available from: http://www.ethnicgroupsphilippines.com/Search in Google Scholar
Nguyen HN. AB035. Thalassemia in Vietnam. Ann Trans Med. 2015; 3(Suppl 2): AB035. doi: 10.3978/j.issn.2305-5839.2015.AB035.NguyenHNAB035Thalassemia in VietnamAnn Trans Med20153(Suppl 2)AB035doi: 10.3978/j.issn.2305-5839.2015.AB035Search in Google Scholar
Weatherall DJ. The challenge of haemoglobinopathies in resource poor countries. Br J Haematol. 2011; 154: 736-44.2172620710.1111/j.1365-2141.2011.08742.xWeatherallDJThe challenge of haemoglobinopathies in resource poor countriesBr J Haematol20111547364421726207Search in Google Scholar
Weatherall DJ. Thalassemia as a global health problem: recent progress toward its control in the developing countries. Ann N Y Acad Sci. 2010; 1202:17-23.2071276710.1111/j.1749-6632.2010.05546.xWeatherallDJThalassemia as a global health problem: recent progress toward its control in the developing countriesAnn N Y Acad Sci20101202172320712767Search in Google Scholar
Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010; 115:4331-6.10.1182/blood-2010-01-25134820233970WeatherallDJThe inherited diseases of hemoglobin are an emerging global health burdenBlood201011543316288149120233970Open DOISearch in Google Scholar
Dhamcharee V, Romyanan O, Ninlagarn T. Genetic counseling for thalassemia in Thailand: problems and solutions. Southeast Asian J Trop Med Public Health. 2001;32: 413-8.11556598DhamchareeVRomyananONinlagarnTGenetic counseling for thalassemia in Thailand: problems and solutionsSoutheast Asian J Trop Med Public Health2001324138Search in Google Scholar
Issaragrisil S. Stem cell transplantation for thalassemia. Int J Hematol. 2002; 76:307-9.1243086910.1007/BF03165269IssaragrisilSStem cell transplantation for thalassemiaInt J Hematol200276307912430869Search in Google Scholar
Vichinsky E, Levine L, Bhatia S, Bojanowski J, Coates T, Levine M (editor), et al. Standards of care guidelines for thalassemia 2012. Oakland, CA: Children’s Hospital and Research Center Oakland. [on line] 2012 [cited 2016 Apr 14] p. 28, Available from: http://thalassemia.com/documents/socguidelines2012.pdfVichinskyELevineLBhatiaSBojanowskiJCoatesTLevineM(editor)Standards of care guidelines for thalassemia 2012Oakland, CAChildren’s Hospital and Research Center Oakland[on line] 2012 [cited 2016 Apr 14]28Available from: http://thalassemia.com/documents/socguidelines2012.pdfSearch in Google Scholar
Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V. Guidelines for the management of non transfusion dependent thalassemia (NTDT). Nicosia (Cyprus): Thalassaemia International Federation. [on line] 2013 [cited 2016 Apr 14]; pp. 1-120, Available from: http://thalassemia.com/documents/NTDT-TIF-guidelines.pdfTaherAVichinskyEMusallamKCappelliniMDViprakasitVGuidelines for the management of non transfusion dependent thalassemia (NTDT)Nicosia (Cyprus)Thalassaemia International Federation[on line] 2013 [cited 2016 Apr 14]1120Available from: http://thalassemia.com/documents/NTDT-TIF-guidelines.pdfSearch in Google Scholar
Tan PHC, Hwang WYK, Goh YT, Tan PL, Koh LP, Tan CH, et al. Unrelated peripheral blood and cord blood hematopoietic stem cell transplants for thalassemia major. Am J Hematol. 2004; 75:209-12.1505481110.1002/ajh.20015TanPHCHwangWYKGohYTTanPLKohLPTanCHUnrelated peripheral blood and cord blood hematopoietic stem cell transplants for thalassemia majorAm J Hematol2004752091215054811Search in Google Scholar
van Be T, van Binh T, Binh N, Tuan T, Nghia H, Hien B. Current status of hematopoietic stem cell transplantations in Vietnam. Bone Marrow Transplant. 2008; 42 (Suppl 1):S146-8.10.1038/bmt.2008.14518724291van BeTvan BinhTBinhNTuanTNghiaHHienBCurrent status of hematopoietic stem cell transplantations in VietnamBone Marrow Transplant200842(Suppl 1)S146818724291Open DOISearch in Google Scholar
